Anti-Tac(Fv)-PE38KDEL conjugateAlternative Names: Anti-Tac(Fv)-PE38KDEL; rDNA anti-Tac immunotoxin
Latest Information Update: 01 Sep 1998
At a glance
- Originator PDL BioPharma
- Mechanism of Action Immunosuppressants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Graft-versus-host disease
Most Recent Events
- 01 Sep 1998 No-Development-Reported for Graft-versus-host disease in USA (Unknown route)
- 23 Aug 1996 New profile
- 23 Aug 1996 Preclinical development for Graft-versus-host disease in USA (Unknown route)